Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
100 Results for "
leucocyte
" in MedChemExpress (MCE) Product Catalog:
Products (100)
100 Results for "leucocyte" in MCE Product Catalog:
Cat. No.: HY-P72517
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRB5; Leukocyte Immunoglobulin-Like Receptor 8; Leukocyte Immunoglobulin Like Receptor B5; CD85 Antigen-Like Family Member C; LIR-8; leucocyte Ig-Like Receptor B5; LIR8; Leukocyte Immunoglobulin Like Receptor B5 Short Splicing Isoform; CD85c; Leukocyte
Species:
Human
Source:
HEK293
Cat. No.: HY-P73506
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD84; Cell Surface Antigen MAX.3; CD84 Molecule; SLAM Family Member 5; SLAMF5; Hly9-Beta; HCD84; Alternative Protein CD84; MCD84; Leukocyte Antigen CD84; Signaling Lymphocytic Activation Molecule 5; leucocyte Differentiation Antigen CD84; CD84 Antigen; Le
Species:
Mouse
Source:
HEK293
Cat. No.: HY-P77063
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Rat
Source:
HEK293
Cat. No.: HY-P77326
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD84; Cell Surface Antigen MAX.3; CD84 Molecule; SLAM Family Member 5; SLAMF5; Hly9-Beta; HCD84; Alternative Protein CD84; MCD84; Leukocyte Antigen CD84; Signaling Lymphocytic Activation Molecule 5; leucocyte Differentiation Antigen CD84; CD84 Antigen; Le
Species:
Rhesus Macaque
Source:
HEK293
Cat. No.: HY-P77441
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA4; CD85 Antigen-Like Family Member G; Leukocyte Immunoglobulin Like Receptor A4; Immunoglobulin-Like Transcript 7; ILT7; leucocyte Ig-Like Receptor A4; CD85g; Leukocyte Immunoglobulin-Like Receptor, Subfamily A (Without TM Domain), Member 4; Leukocyt
Species:
Human
Source:
HEK293
Cat. No.: HY-P77736
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: LILRA4; CD85 Antigen-Like Family Member G; Leukocyte Immunoglobulin Like Receptor A4; Immunoglobulin-Like Transcript 7; ILT7; leucocyte Ig-Like Receptor A4; CD85g; Leukocyte Immunoglobulin-Like Receptor, Subfamily A (Without TM Domain), Member 4; Leukocyt
Species:
Cynomolgus
Source:
HEK293
Cat. No.: HY-P77739
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: LILRB2; Monocyte/Macrophage Immunoglobulin-Like Receptor 10; Leukocyte Immunoglobulin Like Receptor B2; CD85 Antigen-Like Family Member D; MIR-10; Myeloid Inhibitory Receptor 10; LIR-2; leucocyte Ig-Like Receptor B2; MIR10; ILT-4; ILT4; Leukocyte Immunogl
Species:
Cynomolgus
Source:
HEK293
Cat. No.: HY-P77983
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: LILRA2; Leukocyte Immunoglobulin-Like Receptor 7; Leukocyte Immunoglobulin Like Receptor A2; CD85 Antigen-Like Family Member H; LIR-7; Immunoglobulin-Like Transcript 1; ILT1; leucocyte Ig-Like Receptor A2; LIR7; Leukocyte Immunoglobulin-Like Receptor Subf
Species:
Human
Source:
HEK293
Cat. No.: HY-P73506A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD84; Cell Surface Antigen MAX.3; CD84 Molecule; SLAM Family Member 5; SLAMF5; Hly9-Beta; HCD84; Alternative Protein CD84; MCD84; Leukocyte Antigen CD84; Signaling Lymphocytic Activation Molecule 5; leucocyte Differentiation Antigen CD84; CD84 Antigen; Le
Species:
Mouse
Source:
HEK293
Cat. No.: HY-P70875
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA2; Leukocyte Immunoglobulin-Like Receptor 7; Leukocyte Immunoglobulin Like Receptor A2; CD85 Antigen-Like Family Member H; LIR-7; Immunoglobulin-Like Transcript 1; ILT1; leucocyte Ig-Like Receptor A2; LIR7; Leukocyte Immunoglobulin-Like Receptor Subf
Species:
Human
Source:
HEK293
Cat. No.: HY-P72463
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD84; Cell Surface Antigen MAX.3; CD84 Molecule; SLAM Family Member 5; SLAMF5; Hly9-Beta; HCD84; Alternative Protein CD84; MCD84; Leukocyte Antigen CD84; Signaling Lymphocytic Activation Molecule 5; leucocyte Differentiation Antigen CD84; CD84 Antigen; Le
Species:
Human
Source:
HEK293
Cat. No.: HY-P72521
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P75909
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P75910
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Human
Source:
HEK293
Cat. No.: HY-P77062
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: LILRA5; leucocyte Ig-Like Receptor A5; Prev. LILRB7; LIR-9; ILT11; Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 7; LIR9; Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 5 Soluble; CD85f; Immunoglobulin-L
Species:
Rat
Source:
HEK293
Cat. No.: HY-P77325
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD84; Cell Surface Antigen MAX.3; CD84 Molecule; SLAM Family Member 5; SLAMF5; Hly9-Beta; HCD84; Alternative Protein CD84; MCD84; Leukocyte Antigen CD84; Signaling Lymphocytic Activation Molecule 5; leucocyte Differentiation Antigen CD84; CD84 Antigen; Le
Species:
Cynomolgus
Source:
HEK293
Cat. No.: HY-P77443
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: LILRB5; Leukocyte Immunoglobulin-Like Receptor 8; Leukocyte Immunoglobulin Like Receptor B5; CD85 Antigen-Like Family Member C; LIR-8; leucocyte Ig-Like Receptor B5; LIR8; Leukocyte Immunoglobulin Like Receptor B5 Short Splicing Isoform; CD85c; Leukocyte
Species:
Human
Source:
HEK293
Cat. No.: HY-P77737
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: LILRB2; Monocyte/Macrophage Immunoglobulin-Like Receptor 10; Leukocyte Immunoglobulin Like Receptor B2; CD85 Antigen-Like Family Member D; MIR-10; Myeloid Inhibitory Receptor 10; LIR-2; leucocyte Ig-Like Receptor B2; MIR10; ILT-4; ILT4; Leukocyte Immunogl
Species:
Cynomolgus
Source:
HEK293
Cat. No.: HY-P78418
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: CD84; Cell Surface Antigen MAX.3; CD84 Molecule; SLAM Family Member 5; SLAMF5; Hly9-Beta; HCD84; Alternative Protein CD84; MCD84; Leukocyte Antigen CD84; Signaling Lymphocytic Activation Molecule 5; leucocyte Differentiation Antigen CD84; CD84 Antigen; Le
Species:
Human
Source:
HEK293
Cat. No.: HY-P78478
Purity: ≥ 95%, as determined by Bis-Tris PAGE.
Synonyms: LILRB2; Monocyte/Macrophage Immunoglobulin-Like Receptor 10; Leukocyte Immunoglobulin Like Receptor B2; CD85 Antigen-Like Family Member D; MIR-10; Myeloid Inhibitory Receptor 10; LIR-2; leucocyte Ig-Like Receptor B2; MIR10; ILT-4; ILT4; Leukocyte Immunogl
Species:
Human
Source:
HEK293
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
